Tags

Type your tag names separated by a space and hit enter

Misinformation, believability, and vaccine acceptance over 40 countries: Takeaways from the initial phase of the COVID-19 infodemic.
PLoS One. 2022; 17(2):e0263381.Plos

Abstract

The COVID-19 pandemic has been damaging to the lives of people all around the world. Accompanied by the pandemic is an infodemic, an abundant and uncontrolled spread of potentially harmful misinformation. The infodemic may severely change the pandemic's course by interfering with public health interventions such as wearing masks, social distancing, and vaccination. In particular, the impact of the infodemic on vaccination is critical because it holds the key to reverting to pre-pandemic normalcy. This paper presents findings from a global survey on the extent of worldwide exposure to the COVID-19 infodemic, assesses different populations' susceptibility to false claims, and analyzes its association with vaccine acceptance. Based on responses gathered from over 18,400 individuals from 40 countries, we find a strong association between perceived believability of COVID-19 misinformation and vaccination hesitancy. Our study shows that only half of the online users exposed to rumors might have seen corresponding fact-checked information. Moreover, depending on the country, between 6% and 37% of individuals considered these rumors believable. A key finding of this research is that poorer regions were more susceptible to encountering and believing COVID-19 misinformation; countries with lower gross domestic product (GDP) per capita showed a substantially higher prevalence of misinformation. We discuss implications of our findings to public campaigns that proactively spread accurate information to countries that are more susceptible to the infodemic. We also defend that fact-checking platforms should prioritize claims that not only have wide exposure but are also perceived to be believable. Our findings give insights into how to successfully handle risk communication during the initial phase of a future pandemic.

Authors+Show Affiliations

Institute for Basic Science, Daejeon, South Korea.Institute for Basic Science, Daejeon, South Korea. School of Computing, KAIST, Daejeon, South Korea.Institute for Basic Science, Daejeon, South Korea. School of Computing, KAIST, Daejeon, South Korea.College of Nursing, Graduate Program in System Health Science and Engineering, Ewha Womans University, Seoul, South Korea.Department of Politics and Public Administration, University of Konstanz, Konstanz, Germany.Center for Complex Networks and Systems Research, Luddy School of Informatics, Computing, and Engineering, Indiana University, Bloomington, IN, United States of America. Indiana University Network Science Institute, Indiana University, Bloomington, IN, United States of America. Connection Science, Massachusetts Institute of Technology, Cambridge, MA, United States of America.Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul, Turkey.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

35139117

Citation

Singh, Karandeep, et al. "Misinformation, Believability, and Vaccine Acceptance Over 40 Countries: Takeaways From the Initial Phase of the COVID-19 Infodemic." PloS One, vol. 17, no. 2, 2022, pp. e0263381.
Singh K, Lima G, Cha M, et al. Misinformation, believability, and vaccine acceptance over 40 countries: Takeaways from the initial phase of the COVID-19 infodemic. PLoS One. 2022;17(2):e0263381.
Singh, K., Lima, G., Cha, M., Cha, C., Kulshrestha, J., Ahn, Y. Y., & Varol, O. (2022). Misinformation, believability, and vaccine acceptance over 40 countries: Takeaways from the initial phase of the COVID-19 infodemic. PloS One, 17(2), e0263381. https://doi.org/10.1371/journal.pone.0263381
Singh K, et al. Misinformation, Believability, and Vaccine Acceptance Over 40 Countries: Takeaways From the Initial Phase of the COVID-19 Infodemic. PLoS One. 2022;17(2):e0263381. PubMed PMID: 35139117.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Misinformation, believability, and vaccine acceptance over 40 countries: Takeaways from the initial phase of the COVID-19 infodemic. AU - Singh,Karandeep, AU - Lima,Gabriel, AU - Cha,Meeyoung, AU - Cha,Chiyoung, AU - Kulshrestha,Juhi, AU - Ahn,Yong-Yeol, AU - Varol,Onur, Y1 - 2022/02/09/ PY - 2021/04/23/received PY - 2022/01/18/accepted PY - 2022/2/9/entrez PY - 2022/2/10/pubmed PY - 2022/2/23/medline SP - e0263381 EP - e0263381 JF - PloS one JO - PLoS One VL - 17 IS - 2 N2 - The COVID-19 pandemic has been damaging to the lives of people all around the world. Accompanied by the pandemic is an infodemic, an abundant and uncontrolled spread of potentially harmful misinformation. The infodemic may severely change the pandemic's course by interfering with public health interventions such as wearing masks, social distancing, and vaccination. In particular, the impact of the infodemic on vaccination is critical because it holds the key to reverting to pre-pandemic normalcy. This paper presents findings from a global survey on the extent of worldwide exposure to the COVID-19 infodemic, assesses different populations' susceptibility to false claims, and analyzes its association with vaccine acceptance. Based on responses gathered from over 18,400 individuals from 40 countries, we find a strong association between perceived believability of COVID-19 misinformation and vaccination hesitancy. Our study shows that only half of the online users exposed to rumors might have seen corresponding fact-checked information. Moreover, depending on the country, between 6% and 37% of individuals considered these rumors believable. A key finding of this research is that poorer regions were more susceptible to encountering and believing COVID-19 misinformation; countries with lower gross domestic product (GDP) per capita showed a substantially higher prevalence of misinformation. We discuss implications of our findings to public campaigns that proactively spread accurate information to countries that are more susceptible to the infodemic. We also defend that fact-checking platforms should prioritize claims that not only have wide exposure but are also perceived to be believable. Our findings give insights into how to successfully handle risk communication during the initial phase of a future pandemic. SN - 1932-6203 UR - https://www.unboundmedicine.com/medline/citation/35139117/Misinformation_believability_and_vaccine_acceptance_over_40_countries:_Takeaways_from_the_initial_phase_of_the_COVID_19_infodemic_ DB - PRIME DP - Unbound Medicine ER -